About the partner
Joonghun Pharmaceutical Co., Ltd., founded in 2014, is a leader in addressing the challenges of aging through innovative science. Since establishing our R&D center in 2015 and the Cheongju GMP factory in 2016, we’ve focused on developing safe, effective medications, strictly adhering to ICH guidelines to ensure the highest standards of quality.
Our pharmaceutical division offers over 100 MFDS-approved products, including Nexa-V and Adeno-P, which are trusted by top general hospitals for managing age-related pain and inflammation, enhancing patients' quality of life. Beyond pharmaceuticals, we have successfully completed two government-backed research projects on aging, contributing valuable insights to the field through a peer-reviewed publication.
Recognizing that medical aesthetics is essential for holistic aging management, we have developed Lorient Filler and Lorient Element. Lorient Filler, CE-certified for over five years, is celebrated as "The Cleanest" filler available, with the lowest MoD and minimal DIR risk, backed by 14 clinical studies. Lorient Element applies a "Minimally Maximum" approach, delivering potent, scientifically proven ingredients for skin brightening and rejuvenation, optimized for use with EBDs.
Driven by our vision, "Better Solutions for a Healthier, Age-Defying Life," Joonghun strives to empower individuals to age with grace and confidence, integrating medical and aesthetic innovation for comprehensive anti-aging care.
